Vitaspring Biomedical annual working capital
2017
2018
2020
2021
2022
2023
2024
2025
2026
Vitaspring Biomedical Working Capital Growth & History (VSBC)
Vitaspring Biomedical's working capital was −$4.4M for fiscal 2026.
View full Vitaspring Biomedical company overviewVitaspring Biomedical annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | −$4.4M | −$405,411 | — |
| 2025 | 2025-01-31 | −$4.0M | −$565,402 | — |
| 2024 | 2024-01-31 | −$3.5M | −$831,876 | — |
| 2023 | 2023-01-31 | −$2.6M | −$4.0M | — |
| 2022 | 2022-01-31 | $1.3M | $1.2M | +1273.94% |
| 2021 | 2021-01-31 | $96,364 | $96,364 | — |
| 2020 | 2020-01-31 | $0 | — | — |
| 2018 | 2018-01-31 | −$5,293 | −$8,248 | — |
| 2017 | 2017-01-31 | $2,955 | — | — |
Vitaspring Biomedical quarterly working capital
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-04-30 | −$4.5M | −$400,714 | — |
| Q4 2026 | 2026-01-31 | −$4.4M | −$405,411 | — |
| Q3 2026 | 2025-10-31 | −$4.4M | — | — |
| Q2 2026 | 2025-07-31 | −$4.2M | — | — |
| Q1 2026 | 2025-04-30 | −$4.1M | — | — |
| Q4 2025 | 2025-01-31 | −$4.0M | — | — |
| Q4 2023 | 2023-01-31 | −$2.6M | −$4.0M | — |
| Q3 2023 | 2022-10-31 | $1.6M | $1.3M | +531.92% |
| Q2 2023 | 2022-07-31 | $1.6M | $1.1M | +203.72% |
| Q1 2023 | 2022-04-30 | $1.8M | $1.5M | +486.41% |
| Q4 2022 | 2022-01-31 | $1.3M | $1.2M | +1273.94% |
| Q3 2022 | 2021-10-31 | $249,422 | $329,074 | — |
| Q2 2022 | 2021-07-31 | $538,409 | $677,019 | — |
| Q1 2022 | 2021-04-30 | $310,878 | $328,623 | — |
| Q4 2021 | 2021-01-31 | $96,364 | $96,364 | — |
| Q3 2021 | 2020-10-31 | −$79,652 | — | — |
| Q2 2021 | 2020-07-31 | −$138,610 | — | — |
| Q1 2021 | 2020-04-30 | −$17,745 | — | — |
| Q4 2020 | 2020-01-31 | $0 | — | — |
| Q1 2019 | 2018-04-30 | $901 | $1,259 | — |
| Q4 2018 | 2018-01-31 | −$5,293 | −$8,248 | — |
| Q3 2018 | 2017-10-31 | −$1,515 | — | — |
| Q2 2018 | 2017-07-31 | −$1,413 | — | — |
| Q1 2018 | 2017-04-30 | −$358 | — | — |
| Q4 2017 | 2017-01-31 | $2,955 | — | — |
Vitaspring Biomedical working capital trends
Over the last five fiscal years, Vitaspring Biomedical's working capital decreased from $96,364 to −$4.4M, a change of −$4.5M. The latest reported quarter, Q1 2027, shows −$4.5M.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vitaspring Biomedical source filings ↗